Stem definition | Drug id | CAS RN |
---|---|---|
1780 | 4969-02-2 |
Dose | Unit | Route |
---|---|---|
40 | mg | O |
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA | NOVARTIS |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | N04AA03 | NERVOUS SYSTEM ANTI-PARKINSON DRUGS ANTICHOLINERGIC AGENTS Tertiary amines |
CHEBI has role | CHEBI:37956 | antihistamines |
CHEBI has role | CHEBI:48407 | antiparkinson agent |
CHEBI has role | CHEBI:48876 | muscarinic antagonists |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Parkinsonism | indication | 32798002 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 9.34 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 2C | GPCR | ANTAGONIST | CHEMBL | CHEMBL | |||||
Muscarinic acetylcholine receptor M1 | GPCR | ANTAGONIST | CHEMBL | CHEMBL | |||||
Cholinesterase | Enzyme | IC50 | 5.80 | CHEMBL |
ID | Source |
---|---|
D01871 | KEGG_DRUG |
C0066139 | UMLSCUI |
CHEBI:51024 | CHEBI |
CHEMBL1201342 | ChEMBL_ID |
CHEMBL1200426 | ChEMBL_ID |
DB00340 | DRUGBANK_ID |
C005111 | MESH_SUPPLEMENTAL_RECORD_UI |
4167 | PUBCHEM_CID |
7232 | IUPHAR_LIGAND_ID |
7081-40-5 | SECONDARY_CAS_RN |
258230 | RXNORM |
001765 | NDDF |
004712 | NDDF |
323245002 | SNOMEDCT_US |
387354009 | SNOMEDCT_US |
64558005 | SNOMEDCT_US |
1582 | INN_ID |
32VY6L26ZW | UNII |
None